1. Home
  2. CREG vs RVPH Comparison

CREG vs RVPH Comparison

Compare CREG & RVPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

CREG

Smart Powerr Corp.

HOLD

Current Price

$0.34

Market Cap

27.1M

Sector

Utilities

ML Signal

HOLD

Logo Reviva Pharmaceuticals Holdings Inc.

RVPH

Reviva Pharmaceuticals Holdings Inc.

HOLD

Current Price

$0.83

Market Cap

29.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CREG
RVPH
Founded
N/A
2006
Country
China
United States
Employees
N/A
14
Industry
Power Generation
Biotechnology: Pharmaceutical Preparations
Sector
Utilities
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
27.1M
29.2M
IPO Year
2019
N/A

Fundamental Metrics

Financial Performance
Metric
CREG
RVPH
Price
$0.34
$0.83
Analyst Decision
Strong Buy
Analyst Count
0
7
Target Price
N/A
$66.67
AVG Volume (30 Days)
4.7M
2.2M
Earning Date
03-27-2026
03-30-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$867,431.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
12953.89
N/A
52 Week Low
$0.20
$0.17
52 Week High
$2.66
$3.11

Technical Indicators

Market Signals
Indicator
CREG
RVPH
Relative Strength Index (RSI) 17.24 44.82
Support Level $0.20 $0.32
Resistance Level $1.47 $1.16
Average True Range (ATR) 0.26 0.23
MACD -0.08 0.00
Stochastic Oscillator 5.21 23.00

Price Performance

Historical Comparison
CREG
RVPH

About CREG Smart Powerr Corp.

Smart Powerr Corp is a pioneer in waste energy recycling and a developer of energy efficiency solutions for various energy-intensive industries in China. It uses the Build-Operate-Transfer (BOT) model to provide energy-saving and recovery facilities for multiple energy-intensive industries in China. Its waste energy recycling projects allow customers which use substantial amounts of electricity to recapture previously wasted pressure, heat, and gas from their manufacturing processes to generate electricity. The company offers waste energy recycling systems to companies for use in nonferrous metal plants. It constructs its projects at its customer's facility and the electricity produced is used on-site by the customer.

About RVPH Reviva Pharmaceuticals Holdings Inc.

Reviva Pharmaceuticals Holdings Inc is a late-stage pharmaceutical company that discovers, develops, and seeks to commercialize therapeutics for diseases. The current pipeline of the company focuses on the central nervous system, inflammatory, and cardiometabolic diseases. The company uses a chemical genomics-driven technology platform and proprietary chemistry to develop new medicines. The company's pipeline currently has two drug candidates, Brilaroxazine (RP5063) which is intended to treat multiple neuropsychiatric indications, including schizophrenia, bipolar disorder, depressive disorder, attention-deficit/hyperactivity disorder, behavioral and psychotic symptoms of dementia or Alzheimer's disease and Parkinson's disease psychosis and its other drug candidate is RP1208.

Share on Social Networks: